1993
Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells.
Bradley JR, Johnson DR, Pober JS. Four different classes of inhibitors of receptor-mediated endocytosis decrease tumor necrosis factor-induced gene expression in human endothelial cells. The Journal Of Immunology 1993, 150: 5544-55. PMID: 8390537, DOI: 10.4049/jimmunol.150.12.5544.Peer-Reviewed Original ResearchConceptsIFN-gamma-mediated inductionELAM-1Human endothelial cellsEndothelial cellsMHC moleculesReceptor-mediated endocytosisCytokine-inducible moleculesAnti-inflammatory therapyIL-1-induced increaseClass II MHC moleculesICAM-1 expressionClass I MHC moleculesVCAM-1 expressionCultured human endothelial cellsII MHC moleculesI MHC moleculesNew potential targetsICAM-1VCAM-1Levels of mRNADensity lipoproteinExposure of cellsTNFGene expressionTNF induction
1981
Transglutaminase modifies the carboxy-terminal intracellular region of HLA-A and -B antigens
Pober J, Strominger J. Transglutaminase modifies the carboxy-terminal intracellular region of HLA-A and -B antigens. Nature 1981, 289: 819-821. PMID: 6110191, DOI: 10.1038/289819a0.Peer-Reviewed Original Research
1978
Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin.
Pober JS, Iwanij V, Reich E, Stryer L. Transglutaminase-catalyzed insertion of a fluorescent probe into the protease-sensitive region of rhodopsin. Biochemistry 1978, 17: 2163-8. PMID: 27209, DOI: 10.1021/bi00604a021.Peer-Reviewed Original Research